Molecular dissection of box jellyfish venom cytotoxicity highlights an effective venom antidote

Area of Science:

• Toxicology and Pharmacology
• Molecular Biology
• Genomics

Background:

• Chironex fleckeri (box jellyfish) venom is highly toxic, causing rapid tissue necrosis, severe pain, and potentially death.
• The precise molecular mechanisms underlying box jellyfish venom-induced cytotoxicity remain poorly understood.
• Existing treatments for envenomation are limited, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

• To elucidate the host cell components essential for Chironex fleckeri venom-induced cell death.
• To identify potential therapeutic targets for mitigating box jellyfish venom toxicity.
• To discover novel antidotes for box jellyfish stings.

Main Methods:

• Genome-wide lenti-CRISPR mutagenesis screen to identify host factors required for venom-induced cell death.
• Molecular and cellular assays to validate the role of identified host factors.
• Informatics analysis of host gene pathways involved in venom cytotoxicity.
• In vivo testing of a newly discovered venom antidote in a mouse model.

Main Results:

• The peripheral membrane protein ATP2B1 (calcium transporting ATPase) was identified as a critical host factor for venom cytotoxicity.
• Targeting ATP2B1 demonstrated the ability to prevent venom action and provide long-lasting protection against envenomation.
• A novel venom antidote was discovered, effective up to 15 minutes post-exposure, suppressing tissue necrosis and pain in mice.

Conclusions:

• ATP2B1 is a key mediator of Chironex fleckeri venom cytotoxicity, representing a promising therapeutic target.
• Genome-wide CRISPR screening is a powerful tool for dissecting complex venom mechanisms and identifying therapeutic targets.
• The newly identified antidote offers a potential new treatment for box jellyfish stings, improving patient outcomes.